How GLP-1 medications work : - In your brain: They act on appetite centers (especially the hypothalamus) to make you feel full sooner and reduce food cravings and reward-driven eating
Later after 2002, Studies demonstrated that MetS and type 2 diabetes synergistically impact vascular thickness, leading to accelerated carotid intima-media thickness increase, a key marker of subclinical atherosclerosis (15, 16)
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial
Harpreet Tsui, DO, an internal medicine and obesity specialist, explained, We know that abdominal fat releases pro-inflammatory adipokines, increasing systemic inflammation that can trigger or worsen autoimmune diseases
Initially developed to manage diabetes, these medications have shown such effective results in reducing appetite and supporting weight loss that theyve become sought-after solutions for obesity treatment
.webp)
